| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |